Kyntra Bio (KYNB) Net Margin (QoQ) (2014 - 2026)
Kyntra Bio (KYNB) Net Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Kyntra Bio | 30.40 Mn | 30.40 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,231.00 |
| Dec 31, 2025 | -1.98 Mn |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | -33,045.00 |
| Mar 31, 2025 | -6,849.00 |
| Dec 31, 2024 | -2.45 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | 715,534.00 |
| Mar 31, 2024 | 60,648.00 |
| Dec 31, 2023 | 28,612.00 |
| Sep 30, 2023 | 45,251.00 |
| Jun 30, 2023 | 394,617.00 |
| Mar 31, 2023 | -376,775.00 |
| Dec 31, 2022 | -20,608.00 |
| Sep 30, 2022 | -33,949.00 |
| Jun 30, 2022 | 40,266.00 |
| Mar 31, 2022 | 16,434.00 |
| Dec 31, 2021 | -84,426.00 |
| Sep 30, 2021 | 58,396.00 |
| Jun 30, 2021 | 123,563.00 |